Venn sells Innovenn for €5.4m all-share deal
Clinical trials group selling technology development subsidiary to UK firm Integumen
Clinical trials group selling technology development subsidiary to UK firm Integumen
Venn approved to trade shares on Irish Stock Exchange’s ESM as well as on AIM
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices